These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27964952)

  • 21. Genetics and the potential for predictive tests in adverse drug reactions.
    Pirmohamed M
    Chem Immunol Allergy; 2012; 97():18-31. PubMed ID: 22613851
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular Docking for Prediction and Interpretation of Adverse Drug Reactions.
    Luo H; Fokoue-Nkoutche A; Singh N; Yang L; Hu J; Zhang P
    Comb Chem High Throughput Screen; 2018; 21(5):314-322. PubMed ID: 29792141
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expanding role of HLA gene tests for predicting drug side effects.
    Petry N; Forest K; Wilke RA
    Am J Med Sci; 2024 Jan; 367(1):14-20. PubMed ID: 37838157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subangstrom accuracy in pHLA-I modeling by Rosetta FlexPepDock refinement protocol.
    Liu T; Pan X; Chao L; Tan W; Qu S; Yang L; Wang B; Mei H
    J Chem Inf Model; 2014 Aug; 54(8):2233-42. PubMed ID: 25050981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictability of idiosyncratic drug toxicity risk for carboxylic acid-containing drugs based on the chemical stability of acyl glucuronide.
    Sawamura R; Okudaira N; Watanabe K; Murai T; Kobayashi Y; Tachibana M; Ohnuki T; Masuda K; Honma H; Kurihara A; Okazaki O
    Drug Metab Dispos; 2010 Oct; 38(10):1857-64. PubMed ID: 20606003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Computational and Experimental Binding Mechanism of DNA-drug Interactions.
    Selvaraj C; Singh SK
    Curr Pharm Des; 2018; 24(32):3739-3757. PubMed ID: 30398109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of potential toxicity and side effect protein targets of a small molecule by a ligand-protein inverse docking approach.
    Chen YZ; Ung CY
    J Mol Graph Model; 2001; 20(3):199-218. PubMed ID: 11766046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Predictive genomic markers for severe adverse drug reactions].
    Saito Y; Kodama S; Sugiyama E; Nakamura R
    Yakugaku Zasshi; 2015; 135(4):589-95. PubMed ID: 25832839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving drug safety with a systems pharmacology approach.
    Schotland P; Bojunga N; Zien A; Trame MN; Lesko LJ
    Eur J Pharm Sci; 2016 Oct; 94():84-92. PubMed ID: 27287422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using reverse docking for target identification and its applications for drug discovery.
    Lee A; Lee K; Kim D
    Expert Opin Drug Discov; 2016 Jul; 11(7):707-15. PubMed ID: 27186904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting toxicities of reactive metabolite-positive drug candidates.
    Kalgutkar AS; Dalvie D
    Annu Rev Pharmacol Toxicol; 2015; 55():35-54. PubMed ID: 25292426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic activation in drug-induced liver injury.
    Leung L; Kalgutkar AS; Obach RS
    Drug Metab Rev; 2012 Feb; 44(1):18-33. PubMed ID: 21939431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A large-scale computational approach to drug repositioning.
    Li YY; An J; Jones SJ
    Genome Inform; 2006; 17(2):239-47. PubMed ID: 17503396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacoinformatic approaches to understand complexation of dendrimeric nanoparticles with drugs.
    Jain V; Bharatam PV
    Nanoscale; 2014 Mar; 6(5):2476-501. PubMed ID: 24441940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-based virtual screening, molecular docking, ADMET and molecular simulations to develop benzoxaborole analogs as potential inhibitor against Leishmania donovani trypanothione reductase.
    Pandey RK; Kumbhar BV; Sundar S; Kunwar A; Prajapati VK
    J Recept Signal Transduct Res; 2017 Feb; 37(1):60-70. PubMed ID: 27147242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adverse drug reactions triggered by the common HLA-B*57:01 variant: a molecular docking study.
    Van Den Driessche G; Fourches D
    J Cheminform; 2017; 9():13. PubMed ID: 28303164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A zone classification system for risk assessment of idiosyncratic drug toxicity using daily dose and covalent binding.
    Nakayama S; Atsumi R; Takakusa H; Kobayashi Y; Kurihara A; Nagai Y; Nakai D; Okazaki O
    Drug Metab Dispos; 2009 Sep; 37(9):1970-7. PubMed ID: 19487250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is it possible to more accurately predict which drug candidates will cause idiosyncratic drug reactions?
    Uetrecht JP
    Curr Drug Metab; 2000 Sep; 1(2):133-41. PubMed ID: 11465079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Idiosyncratic toxicity: mechanistic insights gained from analysis of prior compounds.
    Waring JF; Anderson MG
    Curr Opin Drug Discov Devel; 2005 Jan; 8(1):59-65. PubMed ID: 15679173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenetics of drug-induced skin blistering disorders. Part I: Perspective.
    Bowman C; Delrieu O
    Pharmacogenomics; 2009 Apr; 10(4):601-21. PubMed ID: 19374517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.